Research library / Longevity compounds

CC Small or few human trials. Promising, not proven. How we grade →RCT (pilot) · 40 adults over 65, 13 weeks

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults: A Pilot Study

G Alsaleh, M Ali, A Kayvanjoo, F Liu, T Moreau, S Bibi et al. Aging Cell. 2026.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
6 mg a day was well tolerated; antibody responses improved only in vaccine non-responders.
Limits
Small pilot, subgroup result; The Longevity Labs supplied product and part-funded; authors consult for it.
Which of our grades it feeds
  • DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Spermidine
Source
doi.org/10.1111/acel.70545 · PubMed 42169618 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.